Publications
204
Citations
11,400
Est. group size
—
Recurring co-author estimate
Active years
25
Publishing since 2002
Samer Gawrieh conducts clinical and translational medical research on liver diseases, with a focus on fatty (steatotic) liver disease and alcohol-associated hepatitis. The work spans diagnostic methods, treatment trials, and studying how factors like HIV infection, metabolic health, and social conditions affect liver disease outcomes.
Publication activity has remained steady and high over the past decade, averaging about 14 papers per year in the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Neighborhood Disadvantage and Access to Liver Transplant Referral for Severe Alcohol-Associated Hepatitis
JAMA Network Open · 2026
- Review Article: An Update on Non‐Invasive Tests for Steatotic Liver Disease ‐ Insights From the ESSENCE Phase 3 Trial and Longitudinal Studies
Alimentary Pharmacology & Therapeutics · 2026
- Assessment of early return to drinking in surviving patients with alcohol‐associated hepatitis
Alcohol Clinical and Experimental Research · 2026
- Non-Hispanic Black Persons With HIV Have a Lower Risk of Metabolic Dysfunction–Associated Steatotic Liver Disease and Clinically Significant Fibrosis Compared to Non-Hispanic White and Hispanic Individuals
Open Forum Infectious Diseases · 2026
- SIRPα Cleavage Is Associated with Inflammatory Response, Corticosteroid Nonresponse, and Worse Prognosis in Clinical and Preclinical Models of Alcohol-Associated Hepatitis
American Journal Of Pathology · 2026
- Mean Arterial Pressure at Admission Predicts 28-day Mortality in Patients with Severe Alcohol-associated Hepatitis
Clinical and Translational Gastroenterology · 2026
- The athero-contour: A novel tool for global and rapid assessment of atherogenic parameters. A use case in saroglitazar treatment of MAFLD patients
Clínica e Investigación en Arteriosclerosis (English Edition) · 2025
- Liver molecular networks associated with drinking behavior in nonhuman primates
Alcohol Clinical and Experimental Research · 2025
- Editorial: <scp>ABID</scp>‐<scp>LSM</scp>–A Promising Model for Predicting Decompensation Risk in <scp>MASLD</scp> Cirrhosis
Alimentary Pharmacology & Therapeutics · 2025
- The association of steatotic liver disease with cardiometabolic criteria and cardiovascular disease risk in a large cohort of people living with human immunodeficiency virus
American Journal of Preventive Cardiology · 2025
- Biological Age, PNPLA3, and Risk of Metabolic Dysfunction-associated Steatotic Liver Disease
Clinical Gastroenterology and Hepatology · 2025
- THU-437 Association of alpha-1 antitrypsin Pi*Z allele and disease severity in metabolic dysfunction-associated steatotic liver disease
Journal of Hepatology · 2025
- Deep Learning Based Shear Wave Detection and Segmentation Tool for Use in Point-of-Care for Chronic Liver Disease Assessments
Ultrasound in Medicine & Biology · 2024
- The athero-contour: A novel tool for global and rapid assessment of atherogenic parameters. A use case in saroglitazar treatment of MAFLD patients
Clínica e Investigación en Arteriosclerosis · 2024
- Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis
Journal of Hepatology · 2024
- Journal of Hepatology×14
- Gastroenterology×14
- Hepatology×11
- Hepatology Communications×11
- The American Journal of Gastroenterology×8
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile